Enochian Biosciences Inc Human Resources Contracts & Agreements
15 Contracts & Agreements
- Bonus & Incentive Agreements (4 contracts)
- Consulting Agreements (8)
- Employment Agreements (3)
- Employment Agreement by and between David Weinstein and Renovaro Inc., dated as of October 14, 2024 (Filed With SEC on November 14, 2024)
- Amended and Restated Consulting Agreement, dated November 4, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC (Filed With SEC on November 8, 2024)
- Consulting Agreement, dated March 11, 2024, by and between Renovaro Inc. and Tarsh PB Advisors LLC (Filed With SEC on March 13, 2024)
- Renovaro Biosciences Inc. 2023 Incentive Plan (Filed With SEC on November 14, 2023)
- Amendment to Employment Agreement between Mark Dybul, M.D. and Enochian Biosciences Inc., dated December 12, 2022 (Filed With SEC on December 16, 2022)
- Employment Agreement between Enochian Biosciences, Inc. and Dr. Mark Dybul, dated August 11, 2021 (Filed With SEC on August 16, 2021)
- Enochian Biosciences, Inc. 2019 Equity Incentive Plan (Filed With SEC on February 10, 2020)
- Consulting Agreement by and between the Company and G-Tech Bio, LLC July 9, 2018 (Filed With SEC on September 30, 2019)
- Consulting Agreement with Carl Sandler (Filed With SEC on May 15, 2018)
- Consulting Agreement with Weird Science (Filed With SEC on May 15, 2018)
- RS Consulting Agreement (Filed With SEC on February 9, 2018)
- DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on March 31, 2014)
- Consulting Agreement (Filed With SEC on March 31, 2014)
- DANDRIT BIOTECH USA, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on February 14, 2014)
- Consulting Agreement (Filed With SEC on February 14, 2014)